Search Results 721-730 of 18540 for Relapse

  1. Medical Research & Education - Mayo Clinic News Network

    Study shows drug reduces risk of relapse with neuromyelitis optica featured image. Featured News. Study shows drug reduces risk of relapse with neuromyelitis ...

  2. Clinical trials - Oncology (Medical)

    ... Relapsed or Refractory NHL. The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or ...

  3. Autoimmune pancreatitis - Diagnosis and treatment - Mayo Clinic

    Sometimes people get better without any treatment. Immunosuppressants and immunomodulators. The disease can relapse. For type 1 AIP , the disease relapses about ...

  4. Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery - Mayo Clinic

    ... relapse of endogenous Cushing's syndrome after surgery. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease ...

  5. Medical Research & Education - Mayo Clinic News Network

    Study shows drug reduces risk of relapse with neuromyelitis optica featured image. Featured News. Study shows drug reduces risk of relapse with neuromyelitis ...

  6. Clinical trials - Oncology (Medical)

    ... Relapsed or Refractory NHL. The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or ...

  7. Corticotropin (intramuscular route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    This medicine will not cure MS, but it may slow some of the disabling effects and decrease the number of flare-ups (relapses) of the disease. Repository ...

  8. Hematology - Clinical trials

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory aggressive B- ...

  9. A Study of JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combination With Daratumumab, Compared With Daratumumab Alone in Participants With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    ... Relapsed or Refractory Multiple Myeloma. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More ...

  10. Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Monoclonal Antibody Ch14.18 in Treating Younger Patients with Refractory or Relapsed Neuroblastoma - Mayo Clinic

    Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Monoclonal Antibody Ch14.18 in Treating Younger Patients with Refractory or Relapsed ...